HK1005188A1 - New thalidomide derivatives method of manufacture and use thereof in medicaments - Google Patents

New thalidomide derivatives method of manufacture and use thereof in medicaments

Info

Publication number
HK1005188A1
HK1005188A1 HK98104297A HK98104297A HK1005188A1 HK 1005188 A1 HK1005188 A1 HK 1005188A1 HK 98104297 A HK98104297 A HK 98104297A HK 98104297 A HK98104297 A HK 98104297A HK 1005188 A1 HK1005188 A1 HK 1005188A1
Authority
HK
Hong Kong
Prior art keywords
medicaments
manufacture
thalidomide derivatives
derivatives method
new
Prior art date
Application number
HK98104297A
Other languages
English (en)
Inventor
Kurt Eger
Gerhard Ehninger
Alfred Stuhler
Original Assignee
Gruenenthal Chemie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruenenthal Chemie filed Critical Gruenenthal Chemie
Publication of HK1005188A1 publication Critical patent/HK1005188A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HK98104297A 1991-04-17 1998-05-19 New thalidomide derivatives method of manufacture and use thereof in medicaments HK1005188A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4112566 1991-04-17
PCT/EP1992/000790 WO1992018496A1 (de) 1991-04-17 1992-04-08 Neue thalidomidderivate, ein verfahren zu deren herstellung sowie die verwendung derselben in arzneimitteln

Publications (1)

Publication Number Publication Date
HK1005188A1 true HK1005188A1 (en) 1998-12-24

Family

ID=6429810

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98104297A HK1005188A1 (en) 1991-04-17 1998-05-19 New thalidomide derivatives method of manufacture and use thereof in medicaments

Country Status (11)

Country Link
EP (1) EP0580641B1 (xx)
JP (1) JP3204972B2 (xx)
AT (1) ATE146787T1 (xx)
AU (1) AU661299B2 (xx)
CA (1) CA2104776C (xx)
DE (2) DE59207778D1 (xx)
DK (1) DK0580641T3 (xx)
ES (1) ES2098505T3 (xx)
GR (1) GR3022175T3 (xx)
HK (1) HK1005188A1 (xx)
WO (1) WO1992018496A1 (xx)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5629327A (en) * 1993-03-01 1997-05-13 Childrens Hospital Medical Center Corp. Methods and compositions for inhibition of angiogenesis
US8143283B1 (en) 1993-03-01 2012-03-27 The Children's Medical Center Corporation Methods for treating blood-born tumors with thalidomide
US6114355A (en) * 1993-03-01 2000-09-05 D'amato; Robert Methods and compositions for inhibition of angiogenesis
DE19613976C1 (de) * 1996-04-09 1997-11-20 Gruenenthal Gmbh Thalidomid-Prodrugs mit immunmodulatorischer Wirkung
CZ389398A3 (cs) * 1996-05-29 1999-07-14 Prototek, Inc. Proléčiva thalidomidu a jejich použití pro modulaci funkce T-buněk
HU228769B1 (en) * 1996-07-24 2013-05-28 Celgene Corp Substituted 2(2,6-dioxopiperidin-3-yl)phthalimides and -1-oxoisoindolines and their use for production of pharmaceutical compositions for mammals to reduce the level of tnf-alpha
NZ336035A (en) 1996-11-05 2002-03-28 Childrens Medical Center Angiogenesis inhibitory composition comprising an inhibitory compound and antiinflammatory drug
DE19703763C1 (de) * 1997-02-01 1998-10-01 Gruenenthal Gmbh Thalidomidanaloge Verbindungen aus der Klasse der Piperidin-2,6-Dione
DE19743968C2 (de) * 1997-10-06 2002-07-11 Gruenenthal Gmbh Intravenöse Applikationsform von Thalidomid zur Therapie immunologischer Erkrankungen
HUP0102113A3 (en) 1998-03-16 2003-03-28 Celgene Corp Warren 2-(2,6-dioxopiperidin-3-yl)isoindoline derivatives, their preparation and their use as inhibitors of inflammatory cytokines
US6673828B1 (en) 1998-05-11 2004-01-06 Children's Medical Center Corporation Analogs of 2-Phthalimidinoglutaric acid
ATE235256T1 (de) 1999-03-31 2003-04-15 Gruenenthal Gmbh Stabile wässrige lösung von 3-(1-oxo-1,3-dihydro- isoindol-2-yl)-piperidin-2,6-dion
US7091353B2 (en) 2000-12-27 2006-08-15 Celgene Corporation Isoindole-imide compounds, compositions, and uses thereof
JP4361273B2 (ja) 2001-02-27 2009-11-11 アメリカ合衆国 潜在的な血管形成阻害剤としてのサリドマイド類似体
CN100488959C (zh) * 2003-03-27 2009-05-20 天津和美生物技术有限公司 水溶性的酞胺哌啶酮衍生物
US8952895B2 (en) 2011-06-03 2015-02-10 Apple Inc. Motion-based device operations
CN1867331B (zh) 2003-09-17 2010-05-26 美国政府健康及人类服务部 作为TNF-α调节剂的沙利度胺类似物
WO2006115509A2 (en) 2004-06-24 2006-11-02 Novartis Vaccines And Diagnostics Inc. Small molecule immunopotentiators and assays for their detection
NZ592425A (en) * 2008-10-29 2013-04-26 Celgene Corp Isoindoline compounds for use in the treatment of cancer
US8927725B2 (en) 2011-12-02 2015-01-06 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Thio compounds

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB768821A (en) * 1954-05-17 1957-02-20 Gruenenthal Chemie Novel products of the amino-piperidine-2, 6-dione series
DE1545672B2 (de) * 1965-05-08 1974-11-07 Chemie Gruenenthal Gmbh, 5190 Stolberg Dikarbonsäureimidderivate und Verfahren zu ihrer Herstellung
DE1670391A1 (de) * 1965-05-08 1970-11-05 Gruenenthal Chemie Dikarbonsaeureimidderivate und Verfahren zu ihrer Herstellung
DE1545706A1 (de) * 1965-05-08 1969-10-09 Gruenenthal Chemie Dicarbonsaeureimidderivate und Verfahren zu ihrer Herstellung

Also Published As

Publication number Publication date
JP3204972B2 (ja) 2001-09-04
DE59207778D1 (de) 1997-02-06
JPH06506671A (ja) 1994-07-28
ATE146787T1 (de) 1997-01-15
DE4211812A1 (de) 1992-10-22
DE4211812C2 (de) 1994-05-05
DK0580641T3 (da) 1997-01-20
AU661299B2 (en) 1995-07-20
GR3022175T3 (en) 1997-03-31
WO1992018496A1 (de) 1992-10-29
EP0580641A1 (de) 1994-02-02
CA2104776A1 (en) 1992-10-18
AU1455592A (en) 1992-11-17
EP0580641B1 (de) 1996-12-27
ES2098505T3 (es) 1997-05-01
CA2104776C (en) 2003-12-09

Similar Documents

Publication Publication Date Title
HK1005188A1 (en) New thalidomide derivatives method of manufacture and use thereof in medicaments
HU9303252D0 (en) New thiopyrano-pyrrole derivatives, pharmaceutical compositions containing them and process for producing them
HU9202172D0 (en) New n-benzoyl-amino-acid derivatives, medical preparatives containing said compounds and method for producing them
HUT70851A (en) Organic salts of n,n`-diacetyl-cystine, pharmaceutical compositions containing them and process for preparing them
HUT49601A (en) Process for producing piperazine derivatives and salts thereof, as well as pharmaceutical compositions comprising such piperazine deriatives and salts thereof
HUT52526A (en) Process for producing enzyme-inhibiting dipeptide-urea derivatives and pharmaceutical compositions containing them
HUT60784A (en) Process for producing n,o-sulfated heparosanes and pharmaceutical compositions comprising such compounds
DE3366923D1 (en) Piperazine derivatives, a process for preparing them and pharmaceutical compositions
HU9701984D0 (en) 3-amido-chromanyl(thio)-urea compounds, process for producing them, their use, and pharmaceutical compositions containing them
HUT49594A (en) Process for producing morpholine derivatives and pharmaceutical comprising these compounds
GB2248838B (en) A new 5H-benzodiazepine derivative,pharmaceutical compositions containing same and process for preparing them
HU9203168D0 (en) Method for preparing pharmaceutical preparatives containing dirythromycine
HU9201621D0 (en) Azetidinyl-substituted pyridone derivatives, method for producing them and pharmaceutical preparatives containing said compounds
IL89401A0 (en) Medicaments containing 1,4-dihydropyridine derivatives for the treatment of alcohol addiction
HUT47132A (en) Process for producing new 2beta, 16beta-diamono-androstane derivatives and pharmaceutical compositions comprising such compounds
YU49079B (sh) Novi derivati fosfolipida i postupak za njihovu proizvodnju
HUT49870A (en) Process for producing new 1,2-dithiolo-3-thion-s-oxide derivatives and pharmaceutical compositions comprising these compounds
HU9202141D0 (en) 2-piperidinyl-pyrimidine-4-carboxamide derivatives, method for producing them and pharmaceutical preparatives containing said compounds
HU913489D0 (en) New benzol(c)fenantridinium derivatives, medical preparations containing them and process for their production
ZA844651B (en) Propan-2-ol derivatives,a process for their production and medicaments containing these compounds
HU914075D0 (en) Thia-diazinone derivatives, process for producing them and pharmaceutical preparatives containing said compounds
HU910325D0 (en) Process for producing hexa-hydro-pyrrholo(2,3-b)indole-carbamate, -urea- and -amide- derivatives and pharmaceutical preparatives containing these compounds
IL94065A0 (en) Diazine derivatives,a process for their preparation and medicaments containing these compounds
AU7070391A (en) O-hydroxy-beta -(1-naphthyl)-propiophenone derivatives, process for producing them and drugs containing them
ZA897553B (en) New 2-methoxycarbonyl substituted n,n'-di-(trimethoxybenzoyl)piperazines,process for preparing the same and therapeutical compounds containing them

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20050408